Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
676
Nova
NVMI
$12.9B
| $11.1M | 0.03% |
+1,227,600
| New | +$11.3M |
|
677
Eldorado Gold
EGO
$10.4B
| $11.1M | 0.03% |
+359,000
| New | +$13.2M |
|
|
VSI
678
DELISTED
Vitamin Shoppe Inc.
VSI
| $11.1M | 0.03% |
+247,500
| New | +$11.6M |
|
679
Littelfuse
LFUS
$11.7B
| $11.1M | 0.03% |
+148,592
| New | +$10.5M |
|
680
Forrester Research
FORR
$220M
| $11.1M | 0.03% |
+301,918
| New | +$10.8M |
|
|
SQI
681
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $11.1M | 0.03% |
+442,100
| New | +$10.3M |
|
|
AMTG
682
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $11.1M | 0.03% |
+671,800
| New | +$13.6M |
|
683
Forward Air
FWRD
$658M
| $11M | 0.03% |
+287,271
| New | +$10.9M |
|
|
MCRL
684
DELISTED
MICREL INC
MCRL
| $11M | 0.03% |
+1,111,179
| New | +$11.1M |
|
|
ANDV
685
DELISTED
Andeavor
ANDV
| $11M | 0.03% |
+209,500
| New | +$11.7M |
|
686
Mattel
MAT
$4.19B
| $10.9M | 0.03% |
+241,200
| New | +$10.8M |
|
687
National Healthcare
NHC
$3.47B
| $10.9M | 0.03% |
+228,500
| New | +$10.7M |
|
|
SSRI
688
DELISTED
Silver Standard Resources
SSRI
| $10.9M | 0.03% |
+1,721,383
| New | +$12.7M |
|
689
Canadian Pacific Kansas City
CP
$81.5B
| $10.9M | 0.03% |
+449,500
| New | +$11.3M |
|
|
KFN
690
DELISTED
KKR FINANCIAL HOLDINGS LLC COM
KFN
| $10.9M | 0.03% |
+1,029,855
| New | +$11M |
|
|
BIRT
691
DELISTED
Actuate Corp
BIRT
| $10.8M | 0.03% |
+1,629,000
| New | +$10.3M |
|
|
STEC
692
DELISTED
STEC INC COM STK
STEC
| $10.8M | 0.03% |
+1,606,310
| New | +$6.23M |
|
|
GWR
693
DELISTED
Genesee & Wyoming Inc.
GWR
| $10.8M | 0.03% |
+127,150
| New | +$11.1M |
|
|
SWY
694
DELISTED
SAFEWAY INC
SWY
| $10.8M | 0.03% |
+509,017
| New | +$11.1M |
|
|
CAMP
695
DELISTED
CalAmp Corp.
CAMP
| $10.8M | 0.03% |
+32,096
| New | +$8.78M |
|
|
MPT
696
Medical Properties Trust
MPT
$2.42B
| $10.8M | 0.03% |
+752,300
| New | +$11.9M |
|
|
CBK
697
DELISTED
Christopher & Banks Corporation
CBK
| $10.7M | 0.03% |
+1,591,900
| New | +$10.8M |
|
|
FL
698
DELISTED
Foot Locker
FL
| $10.7M | 0.03% |
+304,600
| New | +$10.5M |
|
699
Unilever
UL
$133B
| $10.7M | 0.03% |
+234,524
| New | +$11.1M |
|
700
Morningstar
MORN
$7.41B
| $10.6M | 0.03% |
+137,000
| New | +$9.49M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.